Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT)
Faik Gelisken*, Michael Voelker, Rainer Schwabe, Dorothea Besch, Sabine Aisenbrey, Peter Szurman, Salvatore Grisanti, Volker Herzau, Karl Ulrich Bartz-Schmidt
Untersuchen Sie die Forschungsthemen von „Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT)“. Zusammen bilden sie einen einzigartigen Fingerprint.